Dezhi Song

Guangxi Key Laboratory Of Regenerative Medicine
Nanning, 530021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Carnosic acid serves as a dual Nrf2 activator and PTEN/AKT suppressor to inhibit traumatic heterotopic ossification.

Carnosic acid serves as a dual Nrf2 activator and PTEN/AKT suppressor to inhibit traumatic heterotopic ossification.

Journal: Stem cell research & therapy

Published: July 26, 2025

The roles of natural killer cells in bone and arthritic disease: a narrative review.

The roles of natural killer cells in bone and arthritic disease: a narrative review.

Journal: Immunological medicine

Published: May 18, 2025

Single-Cell Transcriptome Analyses of Four Pain Related Genes in Osteosarcoma.

Single-Cell Transcriptome Analyses of Four Pain Related Genes in Osteosarcoma.

Journal: Cancer informatics

Published: October 21, 2024

Trifolirhizin reduces osteoclast formation and prevents inflammatory osteolysis by inhibiting RANKL-induced activation of NF-κB and MAPK signaling pathways and ROS.

Trifolirhizin reduces osteoclast formation and prevents inflammatory osteolysis by inhibiting RANKL-induced activation of NF-κB and MAPK signaling pathways and ROS.

Journal: Phytotherapy research : PTR

Published: October 18, 2023

Three-year experience with combined complex skin repair in patients with extensive burns: a retrospective study.

Three-year experience with combined complex skin repair in patients with extensive burns: a retrospective study.

Journal: Wounds : a compendium of clinical research and practice

Published: September 28, 2023

Advances in SEMA3F regulation of clinically high-incidence cancers.

Advances in SEMA3F regulation of clinically high-incidence cancers.

Journal: Cancer biomarkers : section A of Disease markers

Published: August 21, 2023

CGK733 alleviates ovariectomy-induced bone loss through blocking RANKL-mediated Ca2+ oscillations and NF-κB/MAPK signaling pathways.

CGK733 alleviates ovariectomy-induced bone loss through blocking RANKL-mediated Ca2+ oscillations and NF-κB/MAPK signaling pathways.

Journal: iScience

Published: May 11, 2023

Ethyl caffeate inhibits macrophage polarization via SIRT1/NF-κB to attenuate traumatic heterotopic ossification in mice.

Ethyl caffeate inhibits macrophage polarization via SIRT1/NF-κB to attenuate traumatic heterotopic ossification in mice.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 18, 2022

RNA-seq and Single-Cell Transcriptome Analyses of TRAIL Receptors Gene Expression in Human Osteosarcoma Cells and Tissues.

RNA-seq and Single-Cell Transcriptome Analyses of TRAIL Receptors Gene Expression in Human Osteosarcoma Cells and Tissues.

Journal: Cancer informatics

Published: December 15, 2022

Isosinensetin alleviates estrogen deficiency-induced osteoporosis via suppressing ROS-mediated NF-κB/MAPK signaling pathways.

Isosinensetin alleviates estrogen deficiency-induced osteoporosis via suppressing ROS-mediated NF-κB/MAPK signaling pathways.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: November 17, 2022

Corylifol A protects against ovariectomized-induced bone loss and attenuates RANKL-induced osteoclastogenesis via ROS reduction, ERK inhibition, and NFATc1 activation.

Corylifol A protects against ovariectomized-induced bone loss and attenuates RANKL-induced osteoclastogenesis via ROS reduction, ERK inhibition, and NFATc1 activation.

Journal: Free radical biology & medicine

Published: November 15, 2022

Pharmacology-based molecular docking of 4-methylcatechol and its role in RANKL-mediated ROS/Keap1/Nrf2 signalling axis and osteoclastogenesis.

Pharmacology-based molecular docking of 4-methylcatechol and its role in RANKL-mediated ROS/Keap1/Nrf2 signalling axis and osteoclastogenesis.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 21, 2022

Showing 1-12 of 31

Last Updated: 09/26/2026